Loading company…
Shanghai pharmaceutical company founded in 2001 that researches and produces recombinant prourokinase for injection.
Established in 2001 and based in Shanghai, China, Tasly Pharmaceutical Co., Ltd. focuses on research and development and production of Human recombinant Prourokinase for Injection (pro-UK). It is at the Late stage and operates in the healthcare sector.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in